Omega Flex, Inc. 8K

Omega Flex, Inc. announced weaker second quarter and year-to-date 2026 financial results driven by higher costs and softer demand, alongside the launch of a new TracPipe gas piping fitting and CE mark approval for its MediTrac corrugated medical tubing under EU MDR 2017/745.

Omega Flex, Inc. reported that for the six months ended June 30, 2026, net sales declined 3.5% to $47.2 million and net income fell 38.5% to $4.8 million versus the prior-year period, primarily due to lower sales volumes from a soft housing market and higher raw material, transportation, tariff, marketing, and product enhancement/certification costs, partly offset by lower product liability expenses; management highlighted that a significant portion of the earnings decline relates to higher costs supporting inventory build and the July 1, 2026 launch of a re-engineered TracPipe System flexible gas piping fitting aimed at broader residential and commercial applications, and also announced that its MediTrac corrugated medical tubing received CE mark certification under EU MDR 2017/745 as a Class IIa device in August 2026, positioning the patented, ISO 13485:2016-based product for expanded international medical gas pipeline market opportunities.

Filing Facts

CIK

1317945

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-037334

Alert Tier

6